Therapeutic and management Issues related to skin cancer are dealt with on a daily basis by Dermatologists and lack of a comprehensive therapeutic and management issues can lead to increased morbidity and mortality. This course will be designed to related present key factors that impact on patient care and how to apply current therapies and management approaches. Spirited Questions and Answers with active audience participation will be encouraged. This symposium will work toward delivering practical therapeutic and management solutions to these issues that can be immediately incorporated into the attendee’s patient care setting.
This activity has been approved by the American Board of Dermatology (ABD) for up to 30 MOC Component 2 Self-Assessment points. For more information about MOC, please visit the ABD website at www.abderm.org.
Dr. Rigel / Introduction: Why the issue is Important
Dr. Grant-Kels / Skin Cancer in the Pediatric Population
Dr. Lushniak / Can Public Health make an impact on Indoor Tanning
Dr. Bhatia / Non-Surgical Approaches for BCCs – New Advances
Dr. Lim / Does Photoprotection lower skin cancer risk?
Dr. Ceilley / Field vs Lesional Therapies for AKs – When to use Which?
Dr. Lebwohl / Do Psoriasis therapies increase skin cancer risk?
Dr. Grant-Kels, Dr. Bhatia, Dr. Lim, Dr. Lebwohl, Dr. Lushniak, and Dr. Ceilley / Faculty Q&A
Dr. Rigel / Do Primary and Secondary Melanoma prevention efforts make a difference?
Dr. Curiel-Lewandrowski / Does Serial Imaging Play a Role in Melanoma Management?
Dr. Swetter / What You Need to Know about Advanced MM Therapies – Targeted Approaches
Dr. Desai / Skin Cancer Issues in Skin of Color
Dr. High / Integrating genetics into the diagnosis and management of Melanoma
Dr. Nouri / Current Guidelines for Surgical Management of MM – Margin and SLNBx Recommendations
Dr. Rigel, Dr. Desai, Dr. Curiel-Lewandrowski, Dr. Swetter, Dr. High, and Dr. Nouri / Faculty Q&A